Skip to main content

digital therapeutics

By Thiru Gunasegaran | 04:44 am | June 02, 2021
The digital recovery programme includes consultations with a psychologist and physiotherapist and group therapy and respiratory exercise sessions, among others.
By Dave Muoio | 04:04 pm | April 01, 2021
Former CEO Ed Cox tells the story of Dthera Sciences and outlines how the digital therapeutics landscape has shifted since his company's heyday.
By Dave Muoio | 04:07 pm | March 29, 2021
The digital therapeutic for children's ADHD symptoms received a De Novo clearance last summer.
By Dave Muoio | 12:40 pm | March 17, 2021
The startup's platform now covers more than 20 million lives and is available worldwide.
By Dave Muoio | 03:25 pm | March 10, 2021
The startup will now move onto a larger pivotal trial of the neuromodulation therapy, which received a Breakthrough Device Designation from the FDA in January.
By Dave Muoio | 02:12 pm | March 01, 2021
The investment from "a leading national Integrated Delivery Network" brings the Series D's total to $100 million.
By Dave Muoio | 03:06 pm | February 25, 2021
Industry regulatory leaders outline the best approaches for digital health companies looking to make sense of FDA's long-in-the-tooth enforcement discretion guidelines.
By Mallory Hackett | 01:20 pm | February 25, 2021
Panelists from DTx West share how they successfully executed a digital therapeutic and payer relationship.   
By Dave Muoio | 10:00 am | February 24, 2021
The randomized controlled trial of the jointly-developed digital therapeutics will be conducted using Verily's Project Baseline and enroll up to 540 patients. 
By Dave Muoio | 04:50 pm | February 12, 2021
MobiHealthNews spoke with Pear Therapeutics, Click Therapeutics and DTx newcomer Mahana Therapeutics to discuss whether in-licensing is the way to go for those just entering the space.